In brief
The Nobel Committee awarded the 2026 Chemistry Prize to French chemist Henri B. Kagan and Japanese scientist Kenso Soai for cracking the century‑old mystery of molecular asymmetry in life. Their work shows that amino acids, sugars and other biomolecules exist as two mirror‑image forms, yet living cells use only one. By demonstrating how the tiny kinetic‑resolution step can favour one enantiomer, the pair illuminate a key step toward understanding the origin of biological homochirality. The breakthrough offers a new foundation for synthetic chemistry and could inspire novel drug designs that exploit chirality for greater efficacy.
The 2026 Nobel Prize in Chemistry was awarded to French scientist Henri B. Kagan and Japanese chemist Kenso Soai for solving a fundamental puzzle about life’s molecular handedness.
They showed that molecules crucial for biology — amino acids, sugars and other building blocks — are chiral, meaning they come in two mirror‑image “handed” versions. Life, however, uses only one of these enantiomers. The work provided a clear, experimentally verified mechanism that explains why this single handedness dominates across all living organisms.
“Molecules used by all life are chiral,” the Nobel Committee wrote, “and they have two mirror‑image forms.” The scientists demonstrated a catalytic process that creates a significant excess of one form over the other, a step long believed to be the missing link in the origin of life.
The breakthrough holds major implications for synthetic chemistry, as creating perfectly enantiomerically pure substances is crucial for drug development. It also provides a new theoretical framework for studying the emergence of homochirality in early biosystems.
Kagan and Soai’s findings underscore the power of laboratory chemistry to unlock ancient biological secrets, charting a promising path toward new medical therapies and a deeper grasp of life’s molecular foundations.
